Category Archives: Leading CNS Experience

New Method to Reveal Alzheimer’s Marker Shows Promise – Early study uses drug and imaging scans to pinpoint plaques associated with disease

Lilly wins FDA approval for Alzheimer’s imaging agent

New Lilly drug has small sales potential

NIH’s biomarker consortium releases study data on Alzheimer’s

Prana earns approval to begin Alzheimer’s drug trial

Ocrelizumab Results in MS Published

Second BG-12 Trial Positive in MS

Diffusion-Weighted MRI Guides Stroke Diagnosis

“Faster Alzheimer’s detection in sight” – WCC’s Dr. Richard Walovitch featured in September R&D Directions

Insightec reports success in Parkinson’s study